Requests similar to 'Impact of U.S. FDA Memo on COVID-19 Vaccine Safety Monitoring – Internal Risk Assessment or Policy Review (Nov–Dec 2025)' (page 15)
Incentives relating to Covid-19 vaccine administration
Response by Ministry of Health to ASE on .
Long overdue.
Kia ora
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services
Government Services
Office of the Director-...
Epidemiologist Response to Steve Kisch Excess Death Analysis.
Response by Health New Zealand to M Bell on .
Information not held.
Kia ora M Bell
Thank you for your request for information regarding Epidemiologist
response to excess death analysis on 11 December. Please find...
Consolidated request re COVID-19 inoculations, safety, efficacy, necessity, policy roles, etc
Response by Ministry of Health to ASE on .
Long overdue.
Morena AS Emet
Please find attached a response to your requests for official information.
Ngā mihi
OIA Services
Office of the Direc...
COVID-19 inoculations, long-term safety and efficacy
Response by Ministry of Health to ASE on .
Long overdue.
Morena AS Emet
Please find attached a response to your requests for official information.
Ngā mihi
OIA Services
Office of the Direc...
All cause mortality, by age and inoculation status
Response by Ministry of Health to ASE on .
Long overdue.
Morena AS Emet
Please find attached a response to your requests for official information.
Ngā mihi
OIA Services
Office of the Direc...
Morena AS Emet
Please find attached a response to your requests for official information.
Ngā mihi
OIA Services
Office of the Direc...
Morena AS Emet
Please find attached a response to your requests for official information.
Ngā mihi
OIA Services
Office of the Direc...
COVID-19 inoculations, safety, efficacy, necessity
Response by Ministry of Health to ASE on .
Long overdue.
Morena AS Emet
Please find attached a response to your requests for official information.
Ngā mihi
OIA Services
Office of the Direc...
Notification of the serious effects and deaths in the Pfizer papers released.
Request sent to Ministry of Health by Kiwi Angel on .
Awaiting classification.
Dear Dr Bloomfield
I would like information and correspondence in regards to the Pfizer papers released last week reporting on the results of serious...
Health Advice Provided to Public and Advice provided to Health Sector Ref Spokesperson comment in STUFF.
Request sent to Health New Zealand by M. Fitzgibbon on .
Long overdue.
A recent Stuff Article quoted a Health NZ spokesperson. See quote from the article below:
"A Te Whatu Ora Health New Zealand spokesperson said whi...
Altered composition of Comirnaty BNT162b2
Response by Ministry of Health to Catherine Jamieson on .
Partially successful.
Kia ora Catherine,
Thank you for your email. Below is some further information relating to
Comirnaty (Pfizer/BioNTech) vaccine.
Informatio...
Kia ora
Please find attached a letter regarding your request for information.
Ngā mihi
OIA Services
Government Services
Offic...
Information provided to Covid-19 vaccinators about vaccinating pregnant people
Request sent to Andrew Little by Joan on .
Withdrawn by the requester.
The Ministry of Health, in the COVID-19 update – 9th June, 2021, announced that pregnant people will now be routinely offered the Pfizer mRNA vaccin...
Clarification round Medsafe approval Covid vaccine
Response by Ministry of Health to Jan Magee on .
Successful.
Tçnâ koe Jan,
Thank you for your follow up request under the Official Information Act
1982 (the Act) to Manatû Hauora (Ministry of Health) on 30...
Tçnâ koe AS
Response to your request for official information
Thank you for your request under the Official Information Act 1982 (the
Act)...
https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-vaccines/covid-19-vaccine-advice-specific-groups-and-he...
Differences between BNT162b2 and Comirnaty®
Response by Ministry of Health to ASE on .
Awaiting classification.
Kia ora ASE
Please see attached a response to your request for official information.
Ngā mihi
OIA Services Team
Manatū Ha...
April 2021 Pfizer-BioTech COVID-19 Vaccine safety report on Myocarditis and Pericarditis
Request sent to Ministry of Health by Erika Whittome on .
Information not held.
I understand that one of the gazetted requirements for the Pfizer COvid-19 medicine's provisional approval here https://gazette.govt.nz/notice/id/202...
Kia ora Megan,
Thank you for your email. You asked:
- What are the timeframes Cabinet is working to in order to provide a
decision on the...
Regulatory Status and Use of “Kostaive” (Zapomeran) Vaccine in New Zealand
Request sent to Ministry of Health by John Armstrong on .
Successful.
Under the Official Information Act 1982, I request the following information regarding the COVID-19 vaccine known as Kostaive (active substance: zap...
To meet requirement of transparency and informed consent can you please provide the contract entered into with Pfizer
Response by Ministry of Health to Peter on .
Refused.
Kia ora Peter,
Thank you for your email. The Ministry is unable to provide you with a
copy of the Pfizer contract due to commercial sensitivity....
Kia ora Virginia,
Please find the links in your OIA response below:
[1]www.medsafe.govt.nz/consumers/Safety-ofMedicines/Vaccine-safety.asp.
[2]ww...
Quality assurance Pfizer/BioNTech/Comirnaty/
Response by Ministry of Health to Tracy Livingston on .
Long overdue.
Kia ora Tracy,
Thank you for your request for official information received on 26 January
2022 for:
" Further to this OIA request on the F...
Expert findings about Covid-19 vaccine deaths in Norway
Request sent to Ministry of Health by Ross Francis on .
Information not held.
Between 27 December 2020 to 15 February 2021, the Norwegian Medicines Agency received 100 reports of suspected fatal adverse reactions to the Pfizer...
Advance Purchase Agreements for Covid-19 Vaccines
Response by Ministry of Business, Innovation & Employment to Catherine Jamieson on .
Partially successful.
Kia ora Catherine
Please find attached a letter regarding your requests for information. We
look forward to your response.
Ngā mihi...
